These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 27036548)
1. Prevalence of RhD status and clinical application of non-invasive prenatal determination of fetal RHD in maternal plasma: a 5 year experience in Cyprus. Papasavva T; Martin P; Legler TJ; Liasides M; Anastasiou G; Christofides A; Christodoulou T; Demetriou S; Kerimis P; Kontos C; Leontiades G; Papapetrou D; Patroclos T; Phylaktou M; Zottis N; Karitzie E; Pavlou E; Kountouris P; Veldhuisen B; van der Schoot E; Kleanthous M BMC Res Notes; 2016 Apr; 9():198. PubMed ID: 27036548 [TBL] [Abstract][Full Text] [Related]
2. Non-invasive fetal RHD exon 7 and exon 10 genotyping using real-time PCR testing of fetal DNA in maternal plasma. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Kulovany E; Vlk R Fetal Diagn Ther; 2005; 20(4):275-80. PubMed ID: 15980640 [TBL] [Abstract][Full Text] [Related]
3. Determination of fetal RHD type in plasma of RhD negative pregnant women. Sørensen K; Kjeldsen-Kragh J; Husby H; Akkök ÇA Scand J Clin Lab Invest; 2018 Sep; 78(5):411-416. PubMed ID: 29869532 [TBL] [Abstract][Full Text] [Related]
4. Fetal RhD genotyping by real time quantitative PCR in maternal plasma of RhD-negative pregnant women from the Sahel of Tunisia. Moussa H; Tsochandaridis M; Jemni-Yacoub S; Hmida S; Khairi H; Gabert J; Levy-Mozziconacci A Ann Biol Clin (Paris); 2012; 70(6):683-8. PubMed ID: 23207814 [TBL] [Abstract][Full Text] [Related]
5. Non-invasive fetal RHD genotyping in the first trimester of pregnancy. Cardo L; García BP; Alvarez FV Clin Chem Lab Med; 2010 Aug; 48(8):1121-6. PubMed ID: 20482298 [TBL] [Abstract][Full Text] [Related]
7. The use of maternal plasma for prenatal RhD blood group genotyping. Finning K; Martin P; Daniels G Methods Mol Biol; 2009; 496():143-57. PubMed ID: 18839110 [TBL] [Abstract][Full Text] [Related]
8. A new biosensor for noninvasive determination of fetal RHD status in maternal blood of RhD negative pregnant women. Dündar Yenilmez E; Kökbaş U; Kartlaşmış K; Kayrın L; Tuli A PLoS One; 2018; 13(6):e0197855. PubMed ID: 29874251 [TBL] [Abstract][Full Text] [Related]
10. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. Rouillac-Le Sciellour C; Puillandre P; Gillot R; Baulard C; Métral S; Le Van Kim C; Cartron JP; Colin Y; Brossard Y Mol Diagn; 2004; 8(1):23-31. PubMed ID: 15230639 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive fetal RHD genotyping from maternal plasma in an admixed Brazilian population. Schmidt LC; Cabral AC; Faria MA; Monken F; Tarazona-Santos E; Martins ML Genet Mol Res; 2014 Feb; 13(1):799-805. PubMed ID: 24615044 [TBL] [Abstract][Full Text] [Related]
12. Prenatal non-invasive foetal RHD genotyping: diagnostic accuracy of a test as a guide for appropriate administration of antenatal anti-D immunoprophylaxis. Manfroi S; Calisesi C; Fagiani P; Gabriele A; Lodi G; Nucci S; Pelliconi S; Righini L; Randi V Blood Transfus; 2018 Nov; 16(6):514-524. PubMed ID: 29757138 [TBL] [Abstract][Full Text] [Related]
13. Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium. Minon JM; Gerard C; Senterre JM; Schaaps JP; Foidart JM Transfusion; 2008 Feb; 48(2):373-81. PubMed ID: 18039319 [TBL] [Abstract][Full Text] [Related]
14. Standardization non-invasive fetal RHD and SRY determination into clinical routine using a new multiplex RT-PCR assay for fetal cell-free DNA in pregnant women plasma: results in clinical benefits and cost saving. Macher HC; Noguerol P; Medrano-Campillo P; Garrido-Márquez MR; Rubio-Calvo A; Carmona-González M; Martin-Sánchez J; Pérez-Simón JA; Guerrero JM Clin Chim Acta; 2012 Feb; 413(3-4):490-4. PubMed ID: 22133782 [TBL] [Abstract][Full Text] [Related]
15. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation. Chan FY; Cowley NM; Wolter L; Stone M; Carmody F; Saul A; Hyland CA Prenat Diagn; 2001 Apr; 21(4):321-6. PubMed ID: 11288127 [TBL] [Abstract][Full Text] [Related]
17. Non-invasive prenatal rhesus D genotyping using cell-free foetal DNA. Rather RA; Dhawan V; Saha SC Indian J Med Res; 2019 Jul; 150(1):62-66. PubMed ID: 31571630 [TBL] [Abstract][Full Text] [Related]
19. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Müller SP; Bartels I; Stein W; Emons G; Gutensohn K; Köhler M; Legler TJ Transfusion; 2008 Nov; 48(11):2292-301. PubMed ID: 18694461 [TBL] [Abstract][Full Text] [Related]
20. Non-invasive fetal RHD and RHCE genotyping using real-time PCR testing of maternal plasma in RhD-negative pregnancies. Hromadnikova I; Vechetova L; Vesela K; Benesova B; Doucha J; Vlk R J Histochem Cytochem; 2005 Mar; 53(3):301-5. PubMed ID: 15750007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]